Weighing the Evidence: Variant Classification and Interpretation in Precision Oncology, US Food and Drug Administration Public Workshop—Workshop Proceedings

PURPOSE: Next-generation sequencing (NGS) oncology panels are becoming integral in hospital and academic settings to guide patient treatment and enrollment in clinical trials. Although NGS technologies have revolutionized decision-making for cancer therapeutics, physicians may face many challenges i...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JCO Precis Oncol
Main Authors: Horne, Hisani N., Roscoe, Donna, Litwack, E. David, Pathak, Anand, Pandey, Jai P., Gallagher, Pamela S., Koontz, Laura M., Schuck, Robert N., Lee, Eunice Y., Hu, Yun-Fu, Beaver, Julia A., Blumenthal, Gideon M., Philip, Reena
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2019
Assuntos:
Special Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7446359/
https://ncbi.nlm.nih.gov/pubmed/32914013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.18.00314
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares